Literature DB >> 16630539

Nucleic acid-binding properties of the RRM-containing protein RDM1.

Samia Hamimes1, Dominique Bourgeon, Alicja Z Stasiak, Andrzej Stasiak, Eric Van Dyck.   

Abstract

RDM1 (RAD52 Motif 1) is a vertebrate protein involved in the cellular response to the anti-cancer drug cisplatin. In addition to an RNA recognition motif, RDM1 contains a small amino acid motif, named RD motif, which it shares with the recombination and repair protein, RAD52. RDM1 binds to single- and double-stranded DNA, and recognizes DNA distortions induced by cisplatin adducts in vitro. Here, we have performed an in-depth analysis of the nucleic acid-binding properties of RDM1 using gel-shift assays and electron microscopy. We show that RDM1 possesses acidic pH-dependent DNA-binding activity and that it binds RNA as well as DNA, and we present evidence from competition gel-shift experiments that RDM1 may be capable of discrimination between the two nucleic acids. Based on reported studies of RAD52, we have generated an RDM1 variant mutated in its RD motif. We find that the L119GF --> AAA mutation affects the mode of RDM1 binding to single-stranded DNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630539     DOI: 10.1016/j.bbrc.2006.03.154

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Involvement of p54(nrb), a PSF partner protein, in DNA double-strand break repair and radioresistance.

Authors:  Shuyi Li; Wendy W Kuhne; Anita Kulharya; Farlyn Z Hudson; Kyungsoo Ha; Zhen Cao; William S Dynan
Journal:  Nucleic Acids Res       Date:  2009-09-16       Impact factor: 16.971

2.  Silencing of endo-exonuclease expression sensitizes mouse B16F10 melanoma cells to DNA damaging agents.

Authors:  Sibgat A Choudhury; Paul Kauler; Slobodan Devic; Terry Y-K Chow
Journal:  Invest New Drugs       Date:  2007-05-11       Impact factor: 3.850

Review 3.  The important molecular markers on chromosome 17 and their clinical impact in breast cancer.

Authors:  Wei Zhang; Yingyan Yu
Journal:  Int J Mol Sci       Date:  2011-09-05       Impact factor: 5.923

4.  RDM1 gene overexpression represents a therapeutic target in papillary thyroid carcinoma.

Authors:  Wei Li; Qing Huang; Danyang Sun; Guizhi Zhang; Jian Tan
Journal:  Endocr Connect       Date:  2017-09-22       Impact factor: 3.335

5.  RDM1 promotes neuroblastoma growth through the RAS-Raf-MEK-ERK pathway.

Authors:  Guojin Xie; Haiyan Wu; Weiluo Cai; Mo Chen; Wending Huang; Wangjun Yan; Yong Chang
Journal:  FEBS Open Bio       Date:  2019-01-28       Impact factor: 2.693

6.  Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.

Authors:  Chen Qiu; Zuyin Li; Wanyue Cao; Xiaoni Cai; Li Ye; Cheng Zhang; Yuefeng Ma; Xiaoliang Wang; Yulong Yang
Journal:  Biosci Rep       Date:  2021-09-30       Impact factor: 3.840

7.  Subcellular distribution of human RDM1 protein isoforms and their nucleolar accumulation in response to heat shock and proteotoxic stress.

Authors:  Lydia Messaoudi; Yun-Gui Yang; Aiko Kinomura; Diana A Stavreva; Gonghong Yan; Marie-Line Bortolin-Cavaillé; Hiroshi Arakawa; Jean-Marie Buerstedde; Pierre Hainaut; Jérome Cavaillé; Minoru Takata; Eric Van Dyck
Journal:  Nucleic Acids Res       Date:  2007-09-28       Impact factor: 16.971

8.  A novel small acid soluble protein variant is important for spore resistance of most Clostridium perfringens food poisoning isolates.

Authors:  Jihong Li; Bruce A McClane
Journal:  PLoS Pathog       Date:  2008-05-02       Impact factor: 6.823

9.  Association of RDM1 with osteosarcoma progression via cell cycle and MEK/ERK signalling pathway regulation.

Authors:  Jun Sheng; Kun Liu; Dawei Sun; Piming Nie; Zhiping Mu; Hui Chen; Zhengfeng Zhang
Journal:  J Cell Mol Med       Date:  2021-07-15       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.